Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 3

3(50.0%)

N/A

2(33.3%)

Phase 4

1(16.7%)

6Total

Phase 3(3)

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07496645Phase 3Not Yet Recruiting

EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION ON NAMING IN APHASIC PATIENTS WITH ACUTE ISCHEMIC STROKE

Role: lead

NCT07395531Phase 3Not Yet Recruiting

Effect of Repetitive Bihemispheric Anodal Transcranial Direct Current Stimulation on Motor Function of Patients With Parkinson's Disease

Role: lead

NCT06888375Completed

Humidification Practices During Hospitalized Patients on Non-Invasive Ventilation

Role: lead

NCT07157215Recruiting

An International Survey on the Use of NIV Outside the ICU

Role: lead

NCT03101319Not ApplicableCompleted

Role of Vitamin D Supplementation in Schizophrenia

Role: collaborator

NCT04552392Completed

Psychological Impact of Institutional Quarantine

Role: lead

NCT01879709Not ApplicableCompleted

Yoga as Cognitive Remediation in Schizophrenia

Role: lead

NCT01794897Phase 4Completed

Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia

Role: collaborator

NCT01256918Completed

Study of Phacodepth Required for Safe and Effective Chop During Phacoemulsification for Cataract.

Role: lead

NCT01259349Phase 3Unknown

Effect of Minimising Ultrasound Power to 1% During Cataract Surgery on Corneal Endothelium.

Role: lead

All 10 trials loaded